Alendronic acid/colecalciferol, sold under the brand name Fosamax Plus D among others, is a medication for the treatment of osteoporosis in men or in postmenopausal women. Alendronic acid/colecalciferol was approved for use in the United States and in the European Union in 2005.
Property | Value |
---|---|
dbo:abstract |
|
dbo:alternativeName |
|
dbo:casNumber |
|
dbo:kegg |
|
dbo:wikiPageExternalLink | |
dbo:wikiPageID |
|
dbo:wikiPageLength |
|
dbo:wikiPageRevisionID |
|
dbo:wikiPageWikiLink | |
dbp:atcPrefix |
|
dbp:atcSuffix |
|
dbp:casNumber |
|
dbp:class | |
dbp:component |
|
dbp:dailymedid |
|
dbp:kegg |
|
dbp:legalEu |
|
dbp:legalStatus |
|
dbp:legalUk |
|
dbp:legalUs |
|
dbp:licenceEu |
|
dbp:pregnancyAu |
|
dbp:routesOfAdministration | |
dbp:tradename |
|
dbp:type |
|
dbp:wikiPageUsesTemplate | |
dcterms:subject | |
rdf:type | |
rdfs:comment |
|
rdfs:label |
|
owl:sameAs | |
prov:wasDerivedFrom | |
foaf:isPrimaryTopicOf | |
is dbo:wikiPageRedirects of | |
is dbo:wikiPageWikiLink of |
|
is foaf:primaryTopic of |